|
⚲
|
| Keyboard |
| Halawa Alaa | |
|---|---|
| Firm | |
| Address | 801 Capitola Drive Suite 12 Durham, NC 27713 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Xilis Inc | 021-452383 | Executive Officer | 16.5 M of 16.5 M |
||
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Grant | 46,455 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Disposed to issuer | 28,571 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Disposed to issuer | 46,455 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Grant | 80,000 | $0.00 | |
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Grant | 28,571 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Disposed to issuer | 28,571 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Grant | 46,455 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Grant | 28,571 | ||
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2025-02-13 | Disposed to issuer | 46,455 | ||
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2024-06-13 | Grant | 20,100 | $0.00 | |
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2024-06-13 | Grant | 28,571 | $0.00 | |
|
Neumora Therapeutics Inc NMRA
Stock Option (Right to Buy) · derivative
|
2023-09-14 | Grant | 46,455 | $0.00 |